Racial Disparities in Clinical Manifestation of Crohn’s disease
Main Article Content
Abstract
Introduction: This study aims to evaluate and compare the clinical manifestations and disease progression of CD in African Americans (AA) and Caucasians {CA}.
Methods: We conducted a single-center cross-sectional study of all patients with CD, both hospitalized and seen as outpatient, treated from 2019 to 2024. Chart reviews were used to identify disease location, and perianal disease, strictures, penetrating natures, endoscopy and surgical history, extra intestinal manifestation, demographics, treatment and medication use. Patients with ulcerative colitis or indeterminant colitis were excluded.
Results: A total of 167 patients were identified, comprising 43% AA and 56% Ca. Mean age of diagnosis was 43±14.56 for AA and 47±15.71 for Ca. The average measured BMI was higher in AA (28.55±8.07) than Ca (26.01±5.93) (p<0.01; Table 1). Although there was no significant gender difference in the overall diagnosis of CD, a higher prevalence was observed among females in AA (F/M ratio: 43/27 in AAs vs. 50/45 in Ca). CDs related surgeries occurred in 71% of AA and 56% of Ca. Time from diagnosis to surgery was 17 years for AA and 15 years for Ca with a wide range of standard deviation. No significance differences noted in extraintestinal manifestations, undergoing surgeries, treatment modalities, insurances and perianal disease. AA were more likely to have penetrating phenotype (B3) and less likely to have inflammatory (B1) and stricturing phenotypes (B2) as compared to Caucasians (p<0.005; Table 1). Multivariate logistic regression analysis revealed that the odds of having a B3 phenotype compared to a B1 phenotype were approximately 2.43 times higher for AA compared to Ca (CI: 1.26-4.69) after adjusting for age, sex and BMI. In a subgroup analysis of those with the B3 phenotype, AA were less likely to use steroids compared to Ca (32% Vs 53%, p < 0.05).
Discussion: This study showed that AA were more likely to develop complicated CD over time compared to Ca. Higher BMI was noted among AA, however not correlated with complicated CD. AA were diagnosed younger, had a female predominance, longer time from diagnosis to surgery and underwent more surgeries. These findings suggest that CD may manifest differently in AA, though socioeconomic status, healthcare access, and awareness of the disease process may also play a role.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Malaty HM, Hou JK, Thirumurthi S. Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States. Clin Exp Gastroenterol. 2010;3:165-70. doi:10.2147/CEG.S14586
3. Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. May 2006;101(5):1012-23. doi:10.1111/j.1572-0241.2006.00504.x
4. Jackson JF, 3rd, Dhere T, Repaka A, Shaukat A, Sitaraman S. Crohn's disease in an African-American population. Am J Med Sci. Nov 2008;336(5):389-92. doi:10.1097/MAJ.0b013e31816a5c06
5. Alli-Akintade L, Pruthvi P, Hadi N, Sachar D. Race and fistulizing perianal Crohn's disease. J Clin Gastroenterol. Mar 2015;49(3):e21-3. doi:10.1097/MCG.0000000000000117
6. Brant SR, Okou DT, Simpson CL, et al. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology. Jan 2017;152(1):206-217 e2. doi:10.1053/j.gastro.2016.09.032
7. Huang C, Haritunians T, Okou DT, et al. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. Gastroenterology. Nov 2015;149(6):1575-1586. doi:10.1053/j.gastro.2015.07.065
8. Barnes EL, Kochar B, Long MD, et al. Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. Nov 29 2018;24(12):2634-2640. doi:10.1093/ibd/izy179
9. Kugathasan S, Denson LA, Walters TD, et al. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. Apr 29 2017;389(10080):1710-1718. doi:10.1016/S0140-6736(17)30317-3
10. Walker C, Allamneni C, Orr J, et al. Socioeconomic Status and Race are both Independently associated with Increased Hospitalization Rate among Crohn's Disease Patients. Sci Rep. Mar 5 2018;8(1):4028. doi:10.1038/s41598-018-22429-z
11. Flasar MH, Johnson T, Roghmann MC, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. Jan 2008;14(1):13-9. doi:10.1002/ibd.20298
12. Straus WL, Eisen GM, Sandler RS, Murray SC, Sessions JT. Crohn's disease: does race matter? The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol. Feb 2000;95(2):479-83. doi:10.1111/j.1572-0241.2000.t01-1-01531.x
13. Azevedo RSS, de Sousa JR, Araujo MTF, et al. In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus. Sci Rep. Jan 8 2018;8(1):1. doi:10.1038/s41598-017-17765-5
14. Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol. Oct 2010;105(10):2202-8. doi:10.1038/ajg.2010.202
15. Vust S. [The child facing a serious disease]. Rev Med Suisse Romande. Oct 1994;114(10):915-7. L'enfant face a la maladie grave.
16. Afzali A, Cross RK. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflamm Bowel Dis. Aug 2016;22(8):2023-40. doi:10.1097/MIB.0000000000000835
17. Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clin Gastroenterol Hepatol. Feb 2018;16(2):190-197 e11. doi:10.1016/j.cgh.2017.05.047
18. Walker CH, Arora SS, Colantonio LD, et al. Rates of hospitalization among African American and Caucasian American patients with Crohn's disease seen at a tertiary care center. Gastroenterology Report. 2016;5(4):288-292. doi:10.1093/gastro/gow036
19. Montgomery SR, Jr., Butler PD, Wirtalla CJ, et al. Racial disparities in surgical outcomes of patients with Inflammatory Bowel Disease. Am J Surg. Jun 2018;215(6):1046-1050. doi:10.1016/j.amjsurg.2018.05.011
20. Liu JJ, Abraham BP, Adamson P, et al. The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. Feb 1 2023;29(2):297-307. doi:10.1093/ibd/izac124